Chargement en cours...
Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations
Tenofovir, currently marketed as the prodrug tenofovir disoproxil fumarate, is used clinically to treat patients with HIV/AIDS. The oral bioavailability of tenofovir is relatively low, limiting its clinical effectiveness. Encapsulation of tenofovir within modified long-circulating liposomes would de...
Enregistré dans:
| Publié dans: | Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5327912/ https://ncbi.nlm.nih.gov/pubmed/28260952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S119875 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|